Firebrick Pharma Limited

CHIA:FRE Stock Report

Market Cap: AU$12.6m

Firebrick Pharma Management

Management criteria checks 3/4

Firebrick Pharma's CEO is Peter Molloy, appointed in Apr 2012, has a tenure of 12.08 years. total yearly compensation is A$351.30K, comprised of 80.7% salary and 19.3% bonuses, including company stock and options. directly owns 17.21% of the company’s shares, worth A$2.16M. The average tenure of the management team and the board of directors is 3.4 years and 7.8 years respectively.

Key information

Peter Molloy

Chief executive officer

AU$351.3k

Total compensation

CEO salary percentage80.7%
CEO tenure12.1yrs
CEO ownership17.2%
Management average tenure3.4yrs
Board average tenure7.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Peter Molloy's remuneration changed compared to Firebrick Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-AU$5m

Sep 30 2023n/an/a

-AU$6m

Jun 30 2023AU$351kAU$284k

-AU$7m

Mar 31 2023n/an/a

-AU$6m

Dec 31 2022n/an/a

-AU$5m

Sep 30 2022n/an/a

-AU$5m

Jun 30 2022AU$324kAU$252k

-AU$4m

Mar 31 2022n/an/a

-AU$3m

Dec 31 2021n/an/a

-AU$3m

Sep 30 2021n/an/a

-AU$3m

Jun 30 2021AU$140kAU$140k

-AU$2m

Compensation vs Market: Peter's total compensation ($USD232.00K) is about average for companies of similar size in the Australian market ($USD297.80K).

Compensation vs Earnings: Peter's compensation has increased whilst the company is unprofitable.


CEO

Peter Molloy (69 yo)

12.1yrs

Tenure

AU$351,298

Compensation

Dr. Peter Laurence Molloy, BSc, MBA, FAICD is the Founder, Executive Chairman and Chief Executive Officer of Firebrick Pharma Limited since April 12, 2012. He served as Managing Director and Chief Executiv...


Leadership Team

NamePositionTenureCompensationOwnership
Peter Molloy
Founder12.1yrsAU$351.30k17.21%
A$ 2.2m
Stephen Goodall
Founder12.1yrsAU$290.56k17.21%
A$ 2.2m
Kavi Bekarma
Chief Financial Officer1.4yrsno datano data
Simon Tucker
Chief Scientific Officerno datano data0.56%
A$ 70.0k
Peter Friedland
Chief Medical Officerno datano datano data
Monique Baldwin
Head of Regulatory Affairs2.4yrsno datano data
Stephen Buckley
Company Secretary3.4yrsno datano data

3.4yrs

Average Tenure

Experienced Management: FRE's management team is considered experienced (3.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Peter Molloy
Founder12.1yrsAU$351.30k17.21%
A$ 2.2m
Stephen Goodall
Founder12.1yrsAU$290.56k17.21%
A$ 2.2m
Phyllis Gardner
Independent Non-Executive Director3.5yrsAU$75.00k0.33%
A$ 42.0k
Richard Treagus
Non-Executive Director1.9yrsAU$50.00kno data

7.8yrs

Average Tenure

Experienced Board: FRE's board of directors are considered experienced (7.8 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.